| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |